(Q41605290)

5 October 2017

1 reference

title

Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases (English)

1 reference

5 October 2017

Fowler E

1

1 reference

5 October 2017

Weiner HL

series ordinal

2

1 reference

5 October 2017

publication date

1 January 1997

1 reference

5 October 2017

1 reference

5 October 2017

volume

43

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

323-335

1 reference

The regulation of immune responses to dietary protein antigens

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Mechanisms of self tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Peripheral deletion of antigen-reactive T cells in oral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

21 January 2018

Neonatal oral tolerance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Antigen-driven bystander suppression after oral administration of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Effects of oral administration of type II collagen on rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Inhibition of experimental drug allergy by prior feeding of the sensitizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Oral Tolerance to Myelin Basic Protein Induces Regulatory TGF-β-Secreting T Cells in Peyer's Patches of SJL Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

CD4+ but not CD8+ T cells are required for the induction of oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Impaired mucosal immune responses in interleukin 4-targeted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Effect of oral beta interferon on subsequent immune responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Induction of Interferon-γ, Interleukin-4, and Transforming Growth Factor-β in Rats Orally Tolerized against Experimental Autoimmune Myasthenia Gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of development of experimental autoimmune thyroiditis by oral administration of thyroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Immunosuppression of thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Suppression of Murine Experimental Autoimmune Thyroiditis by Oral Administration of Porcine Thyroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

Downregulation of silicone-induced chronic arthritis by gastric administration of type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281997%2943%3A4%3C323%3A%3AAID-BIP5%3E3.0.CO%3B2-X

10.1002/(SICI)1097-0282(1997)43:4<323::AID-BIP5>3.0.CO;2-X

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference